Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Pharvaris N.V. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 54 | 52 | −2 |
| Shares | 44.6M | 44.9M | +294.9K (+0.7%) |
| Value | $855.8M | $705.5M | −$150.3M (−17.6%) |
New holders (3)
Institutions that held Pharvaris N.V. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rosalind Advisors, Inc. | 223,627 | $3.51M | 1.71% |
| Polygon Management Ltd. | 126,995 | $1.99M | 0.64% |
| Virtus Investment Advisers, Inc. | 8,636 | $135.6K | 0.04% |
Sold out (5)
Institutions that held Pharvaris N.V. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Woodline Partners LP | 44,514 | $853.3K |
| Goldman Sachs Group Inc | 44,247 | $848.2K |
| HealthInvest Partners AB | 34,328 | $652.9K |
| Millennium Management LLC | 17,731 | $339.9K |
| Virtus ETF Advisers LLC | 3,738 | $71.7K |